Cannabidiol (CBD) Market is expected to grow at a CAGR of 20.60% during the forecast period 2022-2029. As per Priority Exploration, the worldwide red biotechnology market size is anticipated to hit around US$ 510 billion by 2027 from an estimated at US$ 322 billion out of 2022. The North America region has the highest market share in the Cannabidiol (CBD) Market, and it is further continuing its dominance during the forecast period.
Our research report gives wide perceptions of the latest trends and development prospects of the market analysis, detailed segmentation analysis, volume, size, share, growth drives, and opportunities in the market. In-depth regional and country-level illustration of the competitive landscape depends on several phases and status of clinical trials over the prominent economies of the globe, and also the report contains a number of major companies profiled in the relevant market.
To Download free sample @ Click Here
Rising commonness of malignant growth, uneasiness and wretchedness problem with the flood in the worldwide geriatric populace
The market is driven by the rising interest commonness of malignant growth, uneasiness and wretchedness problem with the flood in the worldwide geriatric populace. As per the World Wellbeing Association in 2022, malignant growth causes driving passings in overall and it’s around 10 million passings. It encouraged a monstrous interest for CBD to mitigate the side effects of malignant growth illness and give reasonable treatment the assistance of CBD based medications and meds.
Food & Beverages
Personal Care & Cosmetics
By Distribution Channel
Major Companies Covered:
ENDOCA, Cannoid LLC, Isodiol International Inc., Elixinol, Aurora Cannabis Inc., Pharmahemp d.o.o, Folium Biosciences, NuLeaf Naturals LLC, Aphria Inc., Canopy Growth Corp and others.
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States